| Year |
Citation |
Score |
| 2020 |
Borgoni S, Sofyalı E, Soleimani M, Wilhelm H, Müller-Decker K, Will R, Noronha A, Beumers L, Verschure PJ, Yarden Y, Magnani L, van Kampen AHC, Moerland PD, Wiemann S. Time-Resolved Profiling Reveals ATF3 as a Novel Mediator of Endocrine Resistance in Breast Cancer. Cancers. 12. PMID 33050633 DOI: 10.3390/cancers12102918 |
0.337 |
|
| 2020 |
Acar A, Nichol D, Fernandez-Mateos J, Cresswell GD, Barozzi I, Hong SP, Trahearn N, Spiteri I, Stubbs M, Burke R, Stewart A, Caravagna G, Werner B, Vlachogiannis G, Maley CC, ... Magnani L, et al. Exploiting evolutionary steering to induce collateral drug sensitivity in cancer. Nature Communications. 11: 1923. PMID 32317663 DOI: 10.1038/S41467-020-15596-Z |
0.317 |
|
| 2020 |
Cresswell GD, Nichol D, Spiteri I, Tari H, Zapata L, Heide T, Maley CC, Magnani L, Schiavon G, Ashworth A, Barry P, Sottoriva A. Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking. Nature Communications. 11: 1446. PMID 32221288 DOI: 10.1038/S41467-020-15047-9 |
0.366 |
|
| 2020 |
Zwart W, Magnani L, Natrajan R. Decision letter: Single-cell RNA-sequencing reveals distinct patterns of cell state heterogeneity in mouse models of breast cancer Elife. DOI: 10.7554/Elife.58810.Sa1 |
0.344 |
|
| 2020 |
Zoppoli G, Garuti A, Belfiore A, Bonizzi G, Ferrando L, Vingiani A, Colleoni M, Munzone E, Magnani L, Viale G, Ballestrero A, Pruneri G. Abstract PD8-04: Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pd8-04 |
0.398 |
|
| 2020 |
Rocca A, Ravaioli S, Fonzi E, Barozzi I, Perone Y, Magnani L, Pirini F, Martinelli G, Bravaccini S. Abstract P4-07-06: Breast cancer subtype classification using NanoString and RNAseq technologies Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P4-07-06 |
0.408 |
|
| 2020 |
Magnani L, Barozzi I, Hong S. Abstract ES4-2: Single cell transcriptomics reveals multi-step adaptations to endocrine therapy Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Es4-2 |
0.395 |
|
| 2019 |
Hong SP, Chan TE, Lombardo Y, Corleone G, Rotmensz N, Bravaccini S, Rocca A, Pruneri G, McEwen KR, Coombes RC, Barozzi I, Magnani L. Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy. Nature Communications. 10: 3840. PMID 31477698 DOI: 10.1038/S41467-019-11721-9 |
0.368 |
|
| 2019 |
Perone Y, Farrugia AJ, Rodríguez-Meira A, Győrffy B, Ion C, Uggetti A, Chronopoulos A, Marrazzo P, Faronato M, Shousha S, Davies C, Steel JH, Patel N, Del Rio Hernandez A, Coombes C, ... ... Magnani L, et al. Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer. Nature Communications. 10: 3791. PMID 31427580 DOI: 10.1038/S41467-019-11801-W |
0.355 |
|
| 2019 |
Perone Y, Farrugia AJ, Meira AR, Győrffy B, Ion C, Uggetti A, Chronopoulos A, Marrazzo P, Faronato M, Shousha S, Davies C, Steel JH, Patel N, Del Rio Hernandez A, Coombes C, ... ... Magnani L, et al. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer. Nature Communications. 10: 2115. PMID 31073170 DOI: 10.1038/S41467-019-09676-Y |
0.437 |
|
| 2019 |
Varghese V, Magnani L, Harada-Shoji N, Mauri F, Szydlo RM, Yao S, Lam EW, Kenny LM. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression. Scientific Reports. 9: 1505. PMID 30728402 DOI: 10.1038/S41598-018-38017-0 |
0.382 |
|
| 2019 |
Ferrari N, Ranftl R, Chicherova I, Slaven ND, Moeendarbary E, Farrugia AJ, Lam M, Semiannikova M, Westergaard MCW, Tchou J, Magnani L, Calvo F. Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts. Nature Communications. 10: 130. PMID 30631061 DOI: 10.1038/S41467-018-07987-0 |
0.374 |
|
| 2019 |
Perone Y, Rodríguez Meira A, Farruggia A, Győrffy B, Ion C, Pruneri G, Lim A, Calvo F, Magnani L. OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Or34-2 |
0.375 |
|
| 2018 |
Patten DK, Corleone G, Győrffy B, Perone Y, Slaven N, Barozzi I, Erdős E, Saiakhova A, Goddard K, Vingiani A, Shousha S, Pongor LS, Hadjiminas DJ, Schiavon G, Barry P, ... ... Magnani L, et al. Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer. Nature Medicine. PMID 30038216 DOI: 10.1038/S41591-018-0091-X |
0.455 |
|
| 2018 |
Noberini R, Osti D, Miccolo C, Richichi C, Lupia M, Corleone G, Hong SP, Colombo P, Pollo B, Fornasari L, Pruneri G, Magnani L, Cavallaro U, Chiocca S, Minucci S, et al. Extensive and systematic rewiring of histone post-translational modifications in cancer model systems. Nucleic Acids Research. PMID 29618087 DOI: 10.1093/Nar/Gky224 |
0.373 |
|
| 2017 |
Magnani L, Frigè G, Gadaleta RM, Corleone G, Fabris S, Kempe MH, Vershure PJ, Barozzi I, Vircillo V, Hong SP, Perone Y, Saini M, Trumpp A, Viale G, Neri A, et al. Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. Nature Genetics. 49: 970. PMID 28546573 DOI: 10.1038/Ng0617-970B |
0.339 |
|
| 2017 |
Magnani L, Frigè G, Gadaleta RM, Corleone G, Fabris S, Kempe MH, Vershure PJ, Barozzi I, Vircillo V, Hong SP, Perone Y, Saini M, Trumpp A, Viale G, Neri A, et al. Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer. Nature Genetics. PMID 28112739 DOI: 10.1038/Ng.3773 |
0.415 |
|
| 2016 |
Harrod A, Fulton J, Nguyen VT, Periyasamy M, Ramos-Garcia L, Lai CF, Metodieva G, de Giorgio A, Williams RL, Santos DB, Gomez PJ, Lin ML, Metodiev MV, Stebbing J, Castellano L, ... Magnani L, et al. Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene. PMID 27748765 DOI: 10.1038/Onc.2016.382 |
0.374 |
|
| 2016 |
Menyhárt O, Harami-Papp H, Sukumar S, Schäfer R, Magnani L, de Barrios O, Győrffy B. Guidelines For The Selection of Functional Assays To Evaluate The Hallmarks of Cancer. Biochimica Et Biophysica Acta. PMID 27742530 DOI: 10.1016/J.Bbcan.2016.10.002 |
0.335 |
|
| 2016 |
Patel H, Abduljabbar R, Lai CF, Periyasamy M, Harrod A, Gemma C, Steel J, Patel N, Busonero C, Jerjees D, Remenyi J, Smith S, Gomm JJ, Magnani L, Gyorffy B, et al. CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27301701 DOI: 10.1158/1078-0432.Ccr-15-1104 |
0.399 |
|
| 2016 |
Bhat-Nakshatri P, Goswami CP, Badve S, Magnani L, Lupien M, Nakshatri H. Molecular Insights of Pathways Resulting From Two Common PIK3CA Mutations in Breast Cancer. Cancer Research. PMID 27197157 DOI: 10.1158/0008-5472.Can-15-3174 |
0.602 |
|
| 2016 |
Perone Y, Magnani L. Going off the grid: ERα breast cancer beyond estradiol. Journal of Molecular Endocrinology. PMID 27151575 DOI: 10.1530/Jme-16-0062 |
0.409 |
|
| 2015 |
Chen X, Jung JG, Shajahan-Haq AN, Clarke R, Shih IM, Wang Y, Magnani L, Wang TL, Xuan J. ChIP-BIT: Bayesian inference of target genes using a novel joint probabilistic model of ChIP-seq profiles. Nucleic Acids Research. PMID 26704972 DOI: 10.1093/Nar/Gkv1491 |
0.333 |
|
| 2015 |
Nguyen VT, Barozzi I, Faronato M, Lombardo Y, Steel JH, Patel N, Darbre P, Castellano L, Győrffy B, Woodley L, Meira A, Patten DK, Vircillo V, Periyasamy M, Ali S, ... ... Magnani L, et al. Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nature Communications. 6: 10044. PMID 26610607 DOI: 10.1038/Ncomms10044 |
0.374 |
|
| 2015 |
Periyasamy M, Patel H, Lai CF, Nguyen VT, Nevedomskaya E, Harrod A, Russell R, Remenyi J, Ochocka AM, Thomas RS, Fuller-Pace F, Győrffy B, Caldas C, Navaratnam N, Carroll JS, ... ... Magnani L, et al. APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer. Cell Reports. 13: 108-21. PMID 26411678 DOI: 10.1016/J.Celrep.2015.08.066 |
0.42 |
|
| 2015 |
Magnani L, Patten DK, Nguyen VT, Hong SP, Steel JH, Patel N, Lombardo Y, Faronato M, Gomes AR, Woodley L, Page K, Guttery D, Primrose L, Fernandez Garcia D, Shaw J, et al. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer. Oncotarget. PMID 26215677 DOI: 10.18632/Oncotarget.4243 |
0.635 |
|
| 2015 |
Xu Y, Zhang H, Nguyen VT, Angelopoulos N, Nunes J, Reid A, Buluwela L, Magnani L, Stebbing J, Giamas G. LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer. Cell Reports. 12: 837-49. PMID 26212333 DOI: 10.1016/J.Celrep.2015.06.073 |
0.409 |
|
| 2015 |
Faronato M, Nguyen VT, Patten DK, Lombardo Y, Steel JH, Patel N, Woodley L, Shousha S, Pruneri G, Coombes RC, Magnani L. DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through notch hyper-activation. Oncotarget. PMID 26093085 DOI: 10.18632/Oncotarget.4164 |
0.434 |
|
| 2015 |
Okamoto OK, Matheu A, Magnani L. Stem Cells in Translational Cancer Research. Stem Cells International. 2015: 281072. PMID 26078763 DOI: 10.1155/2015/281072 |
0.362 |
|
| 2015 |
Varghese V, Magnani L, Harada N, Eric LW, Kenny L. Abstract A54: Inhibition of FOXM1 by thiostrepton increases sensitivity to 5-fluorouracil (5-FU) by downregulating thymidylate synthase (TS) in colorectal cancer Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-A54 |
0.385 |
|
| 2015 |
Nakshatri H, Goswami C, Badve S, Magnani L, Lupien M, Bhat-Nakshatri P. Abstract P3-05-15: Divergent activation of AKT1 and AKT2 isoforms downstream of PI3K mutation impacts response of breast cancer cells to estradiol and PI3K inhibitors Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-05-15 |
0.619 |
|
| 2014 |
Brown R, Curry E, Magnani L, Wilhelm-Benartzi CS, Borley J. Poised epigenetic states and acquired drug resistance in cancer. Nature Reviews. Cancer. 14: 747-53. PMID 25253389 DOI: 10.1038/Nrc3819 |
0.321 |
|
| 2014 |
Jangal M, Couture JP, Bianco S, Magnani L, Mohammed H, Gévry N. The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes. Nucleic Acids Research. 42: 11339-48. PMID 25223786 DOI: 10.1093/Nar/Gku791 |
0.377 |
|
| 2014 |
Lombardo Y, Faronato M, Filipovic A, Vircillo V, Magnani L, Coombes RC. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells. Breast Cancer Research : Bcr. 16: R62. PMID 24919951 DOI: 10.1186/Bcr3675 |
0.409 |
|
| 2014 |
Bianco S, Brunelle M, Jangal M, Magnani L, Gévry N. LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells. Cancer Research. 74: 2015-25. PMID 24520076 DOI: 10.1158/0008-5472.Can-13-2351 |
0.442 |
|
| 2014 |
Gadaleta RM, Magnani L. Nuclear receptors and chromatin: an inducible couple. Journal of Molecular Endocrinology. 52: R137-49. PMID 24363438 DOI: 10.1530/Jme-13-0170 |
0.314 |
|
| 2014 |
Magnani L, Lupien M. Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling. Molecular and Cellular Endocrinology. 382: 633-41. PMID 23684889 DOI: 10.1016/J.Mce.2013.04.026 |
0.592 |
|
| 2014 |
Varghese V, Magnani L, Harada N, Mauri FA, Lam EW, Kenny LM. Abstract LB-220: Forkhead box transciption factor M1 (FOXM1) plays a critical role in colorectal cancer resistance by regulating thymidylate synthase (TS) Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-220 |
0.401 |
|
| 2013 |
Magnani L, Stoeck A, Zhang X, Lánczky A, Mirabella AC, Wang TL, Gyorffy B, Lupien M. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: E1490-9. PMID 23576735 DOI: 10.1073/Pnas.1219992110 |
0.688 |
|
| 2012 |
Magnani L, Brunelle M, Gévry N, Lupien M. Chromatin landscape and endocrine response in breast cancer. Epigenomics. 4: 675-83. PMID 23244312 DOI: 10.2217/Epi.12.64 |
0.636 |
|
| 2012 |
Magnani L, Carroll J, Zwart W, Palmieri C. ChIPing away at breast cancer. The Lancet. Oncology. 13: 1185-7. PMID 23182190 DOI: 10.1016/S1470-2045(12)70511-9 |
0.377 |
|
| 2012 |
Thiaville MM, Stoeck A, Chen L, Wu RC, Magnani L, Oidtman J, Shih IeM, Lupien M, Wang TL. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites. Plos One. 7: e36054. PMID 22567123 DOI: 10.1371/Journal.Pone.0036054 |
0.615 |
|
| 2012 |
Wang X, Park KE, Koser S, Liu S, Magnani L, Cabot RA. KPNA7, an oocyte- and embryo-specific karyopherin α subtype, is required for porcine embryo development. Reproduction, Fertility, and Development. 24: 382-91. PMID 22281085 DOI: 10.1071/Rd11119 |
0.338 |
|
| 2011 |
Magnani L, Ballantyne EB, Zhang X, Lupien M. PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer. Plos Genetics. 7: e1002368. PMID 22125492 DOI: 10.1371/Journal.Pgen.1002368 |
0.693 |
|
| 2011 |
Magnani L, Eeckhoute J, Lupien M. Pioneer factors: directing transcriptional regulators within the chromatin environment. Trends in Genetics : Tig. 27: 465-74. PMID 21885149 DOI: 10.1016/J.Tig.2011.07.002 |
0.571 |
|
| 2010 |
Wang K, Sengupta S, Magnani L, Wilson CA, Henry RW, Knott JG. Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts. Plos One. 5: e10622. PMID 20485553 DOI: 10.1093/Biolreprod/83.S1.33 |
0.385 |
|
| 2010 |
Park KE, Johnson CM, Magnani L, Wang X, Biancardi MN, Cabot RA. Global H3K9 dimethylation status is not affected by transcription, translation, or DNA replication in porcine zygotes. Molecular Reproduction and Development. 77: 420-9. PMID 20108327 DOI: 10.1002/Mrd.21156 |
0.348 |
|
| 2009 |
Park KE, Magnani L, Cabot RA. Differential remodeling of mono- and trimethylated H3K27 during porcine embryo development. Molecular Reproduction and Development. 76: 1033-42. PMID 19536841 DOI: 10.1002/Mrd.21061 |
0.379 |
|
| 2009 |
Xing X, Magnani L, Lee K, Wang C, Cabot RA, Machaty Z. Gene expression and development of early pig embryos produced by serial nuclear transfer. Molecular Reproduction and Development. 76: 555-63. PMID 18951379 DOI: 10.1002/Mrd.20974 |
0.345 |
|
| 2009 |
Magnani L, Cabot RA. Manipulation of SMARCA2 and SMARCA4 transcript levels in porcine embryos differentially alters development and expression of SMARCA1, SOX2, NANOG, and EIF1. Reproduction (Cambridge, England). 137: 23-33. PMID 18845624 DOI: 10.1530/Rep-08-0335 |
0.365 |
|
| 2009 |
Wang X, Magnani L, Cabot R. 198 Karyopherin Alpha Expression In Porcine Oocytes And Embryos Produced By In Vitro Fertilization Reproduction, Fertility and Development. 21: 197-198. DOI: 10.1071/Rdv21N1Ab198 |
0.648 |
|
| 2009 |
Biancardi MN, Magnani L, Johnson CM, Cabot RA. 178 Transcript Abundance Of Methyltransferases Specific For H3K9 Differ At Discrete Stages Of Porcine Oocyte And Cleavage Stage Embryo Development Reproduction, Fertility and Development. 21: 188-188. DOI: 10.1071/Rdv21N1Ab178 |
0.366 |
|
| 2008 |
Magnani L, Johnson CM, Cabot RA. Expression of eukaryotic elongation initiation factor 1A differentially marks zygotic genome activation in biparental and parthenogenetic porcine embryos and correlates with in vitro developmental potential. Reproduction, Fertility, and Development. 20: 818-25. PMID 18842184 DOI: 10.1071/Rd08072 |
0.364 |
|
| 2008 |
Magnani L, Cabot RA. In vitro and in vivo derived porcine embryos possess similar, but not identical, patterns of Oct4, Nanog, and Sox2 mRNA expression during cleavage development. Molecular Reproduction and Development. 75: 1726-35. PMID 18425776 DOI: 10.1002/Mrd.20915 |
0.339 |
|
| 2008 |
Magnani L, Lee K, Fodor WL, Machaty Z, Cabot RA. Developmental capacity of porcine nuclear transfer embryos correlate with levels of chromatin-remodeling transcripts in donor cells. Molecular Reproduction and Development. 75: 766-76. PMID 18246531 DOI: 10.1002/Mrd.20818 |
0.364 |
|
| 2008 |
Park K, Magnani L, Cabot R. Expression Patterns of H3/K27 Methylation Mediating Genes in Porcine Embryos. Biology of Reproduction. 78: 96-97. DOI: 10.1093/Biolreprod/78.S1.96C |
0.613 |
|
| 2008 |
Magnani L, Cabot R. Ectopic Expression of Brahma in Porcine Embryos Induces Developmental Arrest and Alters Expression of SNF2L. Biology of Reproduction. 78: 72-72. DOI: 10.1093/Biolreprod/78.S1.72 |
0.614 |
|
| 2007 |
Magnani L, Cabot RA. Developmental arrest induced in cleavage stage porcine embryos following microinjection of mRNA encoding Brahma (Smarca 2), a chromatin remodeling protein. Molecular Reproduction and Development. 74: 1262-7. PMID 17342730 DOI: 10.1002/Mrd.20710 |
0.364 |
|
| 2007 |
Biancardi M, Cabot R, Magnani L. The Histone Methyltransferase G9A Adopts A Nuclear Localization In Cleaved Porcine Embryos, But Rarely In Pronuclear Stage Embryos Biology of Reproduction. 77: 89-89. DOI: 10.1093/Biolreprod/77.S1.89A |
0.618 |
|
| 2007 |
Johnson C, Magnani L, Cabot R. Histone Methyltransferase Glp Shows Reduced Amount Of Transcript From The Gv-Stage Oocyte To The 8-Cell Stage In Porcine Parthenogenetic Embryos Biology of Reproduction. 77: 113-113. DOI: 10.1093/Biolreprod/77.S1.113A |
0.636 |
|
| Show low-probability matches. |